Farzan Nima
SEC insider (Form 3/4/5 filer). CIK 0001808296. President and CEO at Latigo Biotherapeutics, Inc. (LTGO) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2026. Located in LEXINGTON, MA.
Companies Farzan Nima has filed insider reports for
- Latigo Biotherapeutics, Inc. (LTGO): Director, Officer, President and CEO
- Keros Therapeutics, Inc. (KROS): Director
Farzan Nima
CIK: 0001808296
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
